Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations?

Hepato-Gastroenterology

Volumn 55, Issue 84, 2008, Pages 1024-1028

  Sikorska, Katarzyna ^a   Stalke, Piotr ^a   Jaskiewicz, Kazimierz ^a   Romanowski, Tomasz ^b   Bielawski, Krzysztof Piotr ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

Author keywords

Hemochromatosis; Hemosiderin; Iron metabolism disorders; Iron overload; Iron binding proteins; Molecular diagnostic techniques; PCR RFLP

Indexed keywords

FERRITIN; HFE PROTEIN; IRON;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IRON BLOOD LEVEL; IRON METABOLISM; IRON STORAGE; LIVER CELL; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY;

ADOLESCENT; ADULT; AGED; DNA MUTATIONAL ANALYSIS; FEMALE; HEMOCHROMATOSIS; HEPATITIS C, CHRONIC; HEPATOCYTES; HETEROZYGOTE DETECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS;

EID: 47149116303     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Cazzola M: Novel genes, proteins and inherited disorders of iron overload: iron metabolism is less boring than thought. Haematologica 2002; 87:115-116.
2. Andrews NC: Disorders of iron metabolism. N Engl J Med 1999; 341:1986-1995.
3. Romanowski T, Sikorska K, Bielawski KP: Molecular basis of hereditary hemochromatosis. Postepy Hig Med Dosw (Online) 2006; 60:217-226. (In Polish]
4. McCord JM: Iron, free radicals and oxidative injury. J Nutr 2004; 134:3171S-3172S.
5. Hübscher SG: Iron overload, inflammation and liver fibrosis in genetic haemochromatosis. J Hepatol 2003; 38:521-525.
6. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G: Survival and causes of death in cirrhotic and in non-cirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313:1256-1262.
7. Silva IS, Perez RM, Oliveira PV, Cantagalo MI, Dantas E, Sisti C, Figuereido-Mendes C, Lanzoni VP, Silva AE, Ferraz ML: Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study. J Gastroenterol Hepatol 2005; 20:243-248.
8. Metwally MA, Zein CO, Zein NN: Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol 2001; 99:286-291.
9. Hemochromatosis. In: Online Mendelian Inheritance in Man. www.ncbi.nlm.nih.gov/omim (05.12.2006)
10. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormischian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK: A novel MHC class 1-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996; 13:399-409.
11. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ: Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34:275-278.
12. Adams PC, Kertesz AE, McLaren CE, Barr R, Bamford A, Chakrabarti S: Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation and C282Y genotyping in 5,211 voluntary blood donors. Hepatology 2000; 31:1160-1164.
13. Distante S, Berg JP, Lande K, Haug E, Bell H: HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut 2000; 47:575-579.
14. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW: A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341:718-724.
15. Ryan E, O'Keane C, Crowe J: Hemochromatosis in Ireland and HFE. Blood Cells Mol Dis 1998; 24:428-432.
16. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK: A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002; 122:646-651.
17. Beutler E, Felitti V, Gelbart T, Hgoc H: The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000; 133:329-337.
18. Sikorska K, Bielawski KP, Romanowski T, Stalke P: Hereditary hemochromatosis: the most frequent inherited human disease. Postepy Hig Med Dosw (Online) 2006; 60:667-676. (In Polish)
19. Pietrangelo A: Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004; 350:2383-2397.
20. Asberg A, Thorstensen K, Hveem K, Bjerve KS: Hereditary hemochromatosis: the clinical significance of the S65C mutation. Genet Test 2002; 6:59-62.
21. Mura C, Raguenes O, Ferec C: HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999; 93:2502-2505.
22. Moczulski DK, Grzeszczak W, Gawlik B: Frequency of the hemochromatosis C282Y and H63D mutations in Polish population of Slavic origin. Med Sci Monit 2001; 7:441-443.
23. Małecki MT, Klupa T, Walus M, Czogala W, Greenlaw P, Sieradzki J: A search for association between hereditary hemochromatosis HFE gene mutations and type 2 diabetes mellitus in a Polish population. Med Sci Monit 2003; 9:BR91-95.
24. Moczulski DK, Grzeszczak W, Gawlik B: Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy. Diabetes Care 2001; 24:1187-1191.
25. Sikorska K, Stalke P, Lakomy EA, Michalska Z, Witczak-Malinowska K, Stolarczyk J: Disturbances of iron metabolism in chronic liver diseases. Med Sci Monit 2003; 9(Suppl 3):64-67.
26. Sikorska K, Bielawski KP, Stalke P, Lakomy EA, Michalska Z, Witczak-Malinowska K, Romanowski T: HFE gene mutations in Polish patients with disturbances of iron metabolism - an initial assessment. Int J Mol Med 2005; 16:1151-1156.
27. Zych WS, Habior A, Rawa T, Butruk E, Ostrowski J: Hemochromatoza wrodzona - pilotowe badanie oceny czȩstości wystepowania w wyselekcjonowanej populacji. Proc and abs book of the XI Congress of Polish Gastroenterologists 2004; pp: 72-72 (In Polish).
28. Harrison SA, Bacon BR: Hereditary hemochromatosis: update for 2003. J Hepatol 2003; 38:S14-S23.
29. Powell LW, George KG, McDonnell SM, Kovdley KV: Diagnosis of hemochromatosis. Ann Intern Med 1998l 129:925-931.
30. Pietrangelo A: Iron, oxidative stress and fibrogenesis. J Hepatol 1998; 28(Suppl 1):8-13.
31. Brissot P, Bourel M, Herry D, Verger JP, Messner M, Beaumont C, Regnouard F, Ferrand B, Simon M: Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 1981; 80:557-565.
32. Turlin B, Deugnier Y: Evaluation and interpretation of iron in the liver. Semin Diagn Pathol 1998; 4:237-245.
33. Menghini G: The needle biopsy of the liver, an effective technical progress. Sci Med Ital 1957; 6:212-229.
34. WHO Report. 2004. The World Health Report 2004. Online:www.who.int.whr/ 2004/en
35. Milman N, Pedersen P: Evidence that Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with Vikings. Clin Genet 2003; 64:36-47.
36. Beutler E: The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997; 61:762-764.
37. Fairbanks VF, Brandhagen DJ, Thibodeau SN, Snow K, Wollan PC: H63D is an haemochromatosis associated allele. Gut 1998; 43:441.
38. Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux GP, Blanc F, Schved JF, Larrey D: Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 2001; 48:836-842.
39. Holmström P, Marmur J, Eggertsen G, Gåfvels M, Stål P: Mild iron overload in patients carrying the HFE S65C mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 2002; 51:723-730.
40. Bridle KR, Crawford DHG, Fletcher LM, Smith JL, Powell LW, Ramm GA: Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis. J Hepatol 2003; 38:426-433.
41. Deugnier YM, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, Jacquelinet C, Brissot P: Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992; 192:2050-2059.
42. Bassett ML, Halliday JW, Powell LW: Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6:24-29.
43. Walker RJ, Miller JP, Dymock IW, Shilkin KB, Wiliams R: Relationship of hepatic iron concentration to histochemical grading and to total chelatahle body iron in conditions associated with iron overload. Gut 1971; 12:1011-1014.